Irritable Bowel Syndrome Chinwon Rim Department of Chemistry Southern Methodist University.

Slides:



Advertisements
Similar presentations
Treatment of irritable bowel syndrome (IBS) and constipation
Advertisements

SAMUEL AGUAZIM (MD) AUTONOMIC NERVOUS SYSTEM PHARMACOLOGY.
Irritable Bowel Syndrome
PHARMACOLOGISTS’ PERSPECTIVE ON COLON PHYSIOLOGY.
Overview of Irritable Bowel Syndrome
How Drugs Enter The Body (1) Oral Administration - substance is ingested through the mouth - digested and absorbed in gastrointestinal tract - passes through.
Stress Any reaction to a physical, emotional, mental or social stimulus Any reaction to a physical, emotional, mental or social stimulus Occasional feeling.
OPIOIDS NIRALI PATEL (2009) Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology.
IBS Irritable Bowel syndrome Prince Sattam Bin AbdulAziz University College Of Pharmacy Mohammad Ruhal Ain R Ph, PGDPRA, M Pharm (Clin. Pharm) Department.
INFECTIONS AND IRRITABLE BOWEL SYNDROME (IBS) By Pebbles Miller.
 ANTIDIARRHEAL DRUGS  Definition of Diarrhea  How to Rx Diarrhea ?   a. Oral Rehydration Therapy (ORT):  Why glucose is important for any rehydration.
Mind-Gut Connections  Janice Singles, Psy.D., Distinguished Psychologist.
Gastrointestinal Disorders Chapter 6 Medical Considerations.
Irritable Bowel Syndrome Rahul Gladwin, MS3 University of Health Sciences Antigua School of Medicine rahul[AT]rahulgladwin.com.
B 尤思涵. Dopamine and Serotonin Dopamine 4-(2-aminoethyl)benzene-1,2-diol 5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol Serotonin.
Diarrhoea and Constipation By Priyanca Patel. What is Constipation? Infrequent bowel movements due to increased transit time or pelvic dysfunction What.
Irritable Bowel Syndrome Biol E-163 TA session 12/18/06.
Irritable Bowel Syndrome Ana Rodriguez. What is it? Irritable bowel syndrome is known as IBS it leads to abdominal pain in which includes pain and cramping.
Assessment and Management of Constipation
Crohn’s Disease Kyra Alexander. What is it? An inflammatory bowel disease that causes inflammation of the digestive tract. It is an unpredictable disease.
IBS In The Elderly Monica J. Cox ARNP-BC, MSN, MPH Geriatric Nurse Practitioner G.I. Nurse Practitioner Borland-Groover Clinic Jacksonville, Florida.
1 Lotronex ® (alosetron HCl) Tablets Risk-Benefit Issues Victor F. C. Raczkowski, M.D. Director, Division of Gastrointestinal and Coagulation Drug Products.
Dr. Abdulrahman Aljebreen.  To know the ◦ pathophysiology, ◦ clinical features and ◦ how to diagnose and ◦ How to manage patients with IBS.
Antidiarrheal Drugs. Normal bowel movement: An average, healthy person has anywhere from three bowel movements a day to three a week, depending on that.
CHEO PROJECT RED ROCKS COMMUNITY COLLEGE NUA 101 – CERTIFIED NURSE AIDE HEALTH CARE SKILLS UNIT 27 GASTROINTESTINAL ELIMINATION.
Irritable Bowel Syndrome 1481 Nadeem Khan March 2, 2015.
Presented By: Asha Davidson and Asmani Patel
Focus on Irritable Bowel Syndrome (IBS)
CMOA HT 4 Receptor Physiology and Pharmacodynamic Effects of Tegaserod Michael Camilleri, MD Gastroenterology Research Unit Mayo Clinic Foundation.
Constipation. Different definitions of constipation have been used in clinical studies → difficulty in characterizing the problem. –< 3 stools / week.
Irritable Bowel Syndrome By: Rocco Paolino. Definition A combination of intermittent abdominal pain, constipation and/or diarrhea.
COMORBIDITIES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME Natalia Pritcan Alina Burianov,Gheata Irina Alina Burianov,Gheata Irina Doctor Melania Macarie.
1 Ellora Islam Jodie Ly Tony Davi Sonaiya Kelley.
CI-1 Zelnorm ® (tegaserod maleate) Gastrointestinal Drugs Advisory Committee Meeting July 14, 2004 Gastrointestinal Drugs Advisory Committee Meeting July.
ADSORBENTS & LAXATIVE By Wiwik Kusumawati. OBJECTIVE At the end of this topic the students will be able to : At the end of this topic the students will.
Diarrhea. Defined as bowel movements which are excessive in volume, frequency, or liquidity. Frequency & consistency of fecal discharge are variable among.
Assessment of Bowels Grampians Regional Continence Service 102 Ascot Street South Ballarat Health Services – Queen Elizabeth Centre
CHAPTER 21: The Psychology of Irritable Bowel Syndrome.
Treatment Arvin M. Aningalan. Treatment Options Patient counseling and dietary alterations Diarrhea – Stool-bulking agents – Antidiarrheal Agents – Serotonin.
SYNAPSE. Our Second Brain: The Stomach By Psychology Today Staff, published on May 01, 1999Psychology Today Staff, published on May 01, 1999 Ever get.
A 2 Alosetron /26 Allen Mangel, M.D., Ph.D. International Director Gastroenterology International Product Development Leader, Alosetron Safety &
1- Irritable Bowel Syndrome (IBS) 2- Constipation
1. What is the most common cause of constipation? A.Pelvic floor dyssynergia B.Slow transit C.Functional D.Mechanical obstruction.
IN 1 NDA Gastrointestinal Advisory Committee Meeting Gaithersburg, Maryland June 26, 2000 Gastrointestinal Advisory Committee Meeting Gaithersburg,
The physiological and pathophysiological roles of the Urocortins Krisztina Kárpáti and Hélène Rivière JPEMS
Conclusions Sidney Cohen, MD Chairman, Department of Medicine Temple University School of Medicine Philadelphia, Pennsylvania Sidney Cohen, MD Chairman,
27 June 2000Victor F. C. Raczkowski, M.D.1 Benefit-Risk Reevaluation of Marketed Drugs Victor F. C. Raczkowski, M.D., M.S. Gastrointestinal Drugs Advisory.
Laxatives and Antidiarrheals
Neurotransmissions in the Central Nervous System Prof. Alhaider.
Constipation 변비 2013 년 3 월 24 일 서울의대 내과학교실, 서울대학교병원 홍 경 섭 질병의 병태생리학.
IBS (Irritable Bowel Syndrome)
A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation Michael Camilleri, M.D., Rene Kerstens, M.Sc., An Rykx, Ph.D., and Lieve Vandeplassche,
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Randomized Controlled Clinical Trial of the Serotonin.
Kingdom of Saudi Arabia Alghad collages –Tabuk girls.
1- Irritable Bowel Syndrome (IBS) 2- Constipation
Focus on Irritable Bowel Syndrome (IBS)
Irritable bowel syndrome
IRRITABLE BOWEL SYNDROME
Appendix Appendix : is a small, finger-shaped that projects from colon on the lower right side of abdomen. Appendicitis: is inflammation of the appendix.
Opioids and the gut Job bag number: NP-EU-NAL-0059
Drugs for the treatment of irritable bowel syndrome (IBS)
Common Functional Gastroenterological Disorders Associated With Abdominal Pain  Adil E. Bharucha, MBBS, MD, Subhankar Chakraborty, MBBS, PhD, Christopher.
Management of the irritable bowel syndrome
GI Disorders.
Management of Constipation in Adults
School of Pharmacy, University of Nizwa
School of Pharmacy, University of Nizwa
Human Digestive System
Opioids and the gut Job bag number: NP-EU-NAL-0059
Presentation transcript:

Irritable Bowel Syndrome Chinwon Rim Department of Chemistry Southern Methodist University

What is Irritable Bowel Syndrome(IBS)? A group of functional bowel disorders Chronic abdominal complaints without a structural or biochemical cause Constitutes a major health problem with gastrointestinal (GI) symptoms The cause of IBS is unknown. Affects up to ~20 % adults in the industrialized world The condition is more frequent in women. The direct medical costs of IBS are ~ $ US 8 billion in the US each year.

Symptoms of IBS Abdominal discomfort and pain Bloating, mucous in stools, diarrhea, constipation, or alternating diarrhea and constipation Depression, anxiety or stress IBS can be subdivided into  Diarrhea-predominant (IBS-D)  Constipation-predominant (IBS-C)  Alternating diarrhea and constipation

Subclassification of patients Supportive symptoms of IBS 1. Fewer than 3 bowel movements a week 2. More than 3 bowel movements a day 3. Hard or lumpy stools 4. Loose or watery stools 5. Urgency 6. Feeling of incomplete bowel movement 7. Passing mucus during a bowel movement 8. Abdominal fullness, bloating or swelling Diarrhea-predominant IBS (IBS-D)  One or more of 2, 4 or 6 and none of 1, 3 or 5 Constipation-predominant IBS (IBS-C)  One or more of 1, 3 or 5 and none of 2, 4 or 6

Serotonin is important in gut function GI disorders may be related to  an imbalance of serotonin in the gut  an improper reaction of the digestive system to serotonin  a faulty communication network between serotonin in the gut and the brain and spinal cord. Serotonin plays a major role in modulating intestinal movement and perception of pain. Helps to soften stools by releasing water.

Serotonin (5-hydroxytryptamine, 5HT) A monoamine neurotransmitter Found in cardiovascular tissue, the peripheral nervous system, blood cells, and the CNS 95 % resides in the GI tract Serotonergic neurons secrete 5HT The function of serotonin is exerted upon its interaction with specific receptors. 7 distinct families of 5HTreceptors; 5HT 1, 5HT 2, 5HT 3, 5HT 4, 5HT 5, 5HT 6, and 5HT 7

5HT 3 receptors and its antagonists 5HT 3 receptors  A ligand-gated cation channel  Present in the GI tract  Control sensation, contraction of intestinal muscle  Release of fluid into the intestines 5HT 3 antagonists  Slow intestinal transit  Decrease intestinal secretions  Decrease the water content of stool  Diminish colonic pain

5HT 4 receptors and its agonists 5HT 4 receptors  G-protein-coupled receptor  Present in the GI tract  Mediate both relaxation and contraction of circular smooth-muscle strips  Induces small bowel and to a lesser extent colonic fluid secretion 5HT 4 agonists  Accelerate gastric emptying  Accelerate small and large bowel transit  Increase stool water content

Alosetron in IBS-D The first drug is approved for female patients by FDA Brand name is Lotronex ® by Glaxo Smith Kline A potent and selective antagonist of the 5HT 3 receptors

Synthetic pathway of alosetron (i) NaH, dimethoxyethane; (ii) HCl.

How does alosetron works? The exact mechanism how alosetron relieves the symptoms of IBS-D is unknown. Serotonin in the intestines controls how pain is felt, contraction of intestinal muscle, and release of fluid into the intestines. An excessive release of or an excessive response to serotonin causes a pain and diarrhea. By blocking 5HT 3 receptors, alosetron reduced pain and motor responses.

Alosetron-New Drug for IBS-D Alosetron is rapidly absorbed and extensively metabolized. Effective in relieving pain, normalizing bowel frequency, and reducing urgency Constipation is the most common adverse effect Appears to provide a modest benefit to women Should be prescribed under the guidance of a specialist Serious side effects and high-cost maintenance problem

T egaserod in IBS-C The first selective serotonin 5HT 4 receptor partial agonist approved by FDA for the treatment of abdominal pain and constipation predominent IBS patients Brand name is Zelnorm TM by Novartis Pharmceu. Corp.

Synthetic pathway of tegaserod (i) K 2 CO 3, RBr or ClCOX; (ii) t-BuOCH(NMe 2 ) 2 then H 2, Pd/C; (iii) DMF, POCl 3 ; and (v) N-pentyl-N’-aminoguanidine, MeOH/HCl.

How does tegaserod work? The exact mechanism of tegaserod’s action is not yet understood completely. Tegaserod binds with high affinity at 5HT 4 receptors. The activation of 5HT 4 receptors in GI tract stimulates the peristaltic reflex and intestinal secretion. As a result, contractions increase and the increased contractions speed the transit of digesting food and reverse constipation. Reduces the sensitivity of the intestinal pain-sensing nerves and reduces pain by inhibiting visceral sensitivity

Tegaserod –a Promising Option Tegaserod is rapidly absorbed and metabolized. Effective in increasing the frequency of stools, relieving abdominal pain and discomfort, and decreasing the sensations of bloating Diarrhea is an occasional side effect. Is approved only for women Should be prescribed under the guidance of a specialist

Conclusions Alosetron, 5HT 3 antagonists, appears to provide a modest benefit to women with IBS-D. Offers a new option for the treatment of IBS-D. Tegaserod, 5HT 4 agonists, appears to be a promising options in women with IBS-C not responding to increased dietary fiber or laxative therapy. Both cases, need more researches on mechanism how drugs work and clinical studies for the treatment of men patients. Need to discover new drugs for alternating diarrhea and constipation

References 1. De Ponti, F.; Tonini, M. Drugs 2001, 61(3), Lembo, A.; Weber, H. C.; Farraye, F. A. Drugs 2003, 63(18), Talley, N. J. Lancet 2001, 358(9298), Coates, I. H. O., Alexander William; North, Peter Charles; Tyers, Michael Brian. Eur. Pat. Appl. (1990), 9 pp. 6. Buchheit, K.-H.; Gamse, R.; Giger, R.; Hoyer, D.; Klein, F.; Kloppner, E.; Pfannkuche, H.-J.; Mattes, H. Journal of medicinal chemistry 1995, 38(13), Camilleri, M. Aliment Pharmacol Ther 2001, 15(3), Appel-Dingemanse, S. Clin Pharmacokinet 2002, 41(13),